<SEC-DOCUMENT>0001047469-18-004571-index.html : 20180619 <SEC-HEADER>0001047469-18-004571.hdr.sgml : 20180619 <ACCEPTANCE-DATETIME>20180619161726 ACCESSION NUMBER: 0001047469-18-004571 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20180801 FILED AS OF DATE: 20180619 DATE AS OF CHANGE: 20180619 EFFECTIVENESS DATE: 20180619 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 18907332 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>a2235997zdef14a.htm <DESCRIPTION>DEF 14A <TEXT> Document 1 - file: a2235997zdef14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>g285256.jpg <DESCRIPTION>G285256.JPG <TEXT> Document 2 - file: g285256.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>g761950.jpg <DESCRIPTION>G761950.JPG <TEXT> Document 3 - file: g761950.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g151972bgi001.gif <DESCRIPTION>G151972BGI001.GIF <TEXT> Document 4 - file: g151972bgi001.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g151972bgi002.gif <DESCRIPTION>G151972BGI002.GIF <TEXT> Document 5 - file: g151972bgi002.gif
</DOCUMENT> </SEC-DOCUMENT>